| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 4240338
[patent_doc_number] => 06080779
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-06-27
[patent_title] => 'Compositions and methods for stimulating bone growth'
[patent_app_type] => 1
[patent_app_number] => 9/096957
[patent_app_country] => US
[patent_app_date] => 1998-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 12300
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 212
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/080/06080779.pdf
[firstpage_image] =>[orig_patent_app_number] => 096957
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/096957 | Compositions and methods for stimulating bone growth | Jun 11, 1998 | Issued |
| 09/096631 | ISOPRENOID PATHWAY INHIBITORS FOR STIMULATING BONE GROWTH | Jun 11, 1998 | Abandoned |
Array
(
[id] => 4092987
[patent_doc_number] => 06096511
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-08-01
[patent_title] => 'Protein elongation factor 2 as a target for antifungal and antiparasitic agents'
[patent_app_type] => 1
[patent_app_number] => 9/089307
[patent_app_country] => US
[patent_app_date] => 1998-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4529
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/096/06096511.pdf
[firstpage_image] =>[orig_patent_app_number] => 089307
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/089307 | Protein elongation factor 2 as a target for antifungal and antiparasitic agents | Jun 1, 1998 | Issued |
| 09/087230 | LIQUID REAGENT SET FOR L-LACTATE DETERMINATION | May 28, 1998 | Abandoned |
Array
(
[id] => 4101102
[patent_doc_number] => 06051390
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-04-18
[patent_title] => 'Complex-bound inhibitors of metabolic enzymes capable of being activated, useful as molecular markers for diagnostic and therapy monitoring purposes'
[patent_app_type] => 1
[patent_app_number] => 9/029867
[patent_app_country] => US
[patent_app_date] => 1998-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3056
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/051/06051390.pdf
[firstpage_image] =>[orig_patent_app_number] => 029867
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/029867 | Complex-bound inhibitors of metabolic enzymes capable of being activated, useful as molecular markers for diagnostic and therapy monitoring purposes | May 25, 1998 | Issued |
Array
(
[id] => 4251985
[patent_doc_number] => 06207656
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-03-27
[patent_title] => 'Vitamin D analogues and their neuronal effects'
[patent_app_type] => 1
[patent_app_number] => 9/082762
[patent_app_country] => US
[patent_app_date] => 1998-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 22
[patent_no_of_words] => 11400
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 116
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/207/06207656.pdf
[firstpage_image] =>[orig_patent_app_number] => 082762
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/082762 | Vitamin D analogues and their neuronal effects | May 20, 1998 | Issued |
Array
(
[id] => 1565246
[patent_doc_number] => 06376209
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2002-04-23
[patent_title] => 'Increasing the FVII sensitivity of a thromboplastin reagent'
[patent_app_type] => B2
[patent_app_number] => 09/078760
[patent_app_country] => US
[patent_app_date] => 1998-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5048
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/376/06376209.pdf
[firstpage_image] =>[orig_patent_app_number] => 09078760
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/078760 | Increasing the FVII sensitivity of a thromboplastin reagent | May 14, 1998 | Issued |
Array
(
[id] => 4144420
[patent_doc_number] => 06063591
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-05-16
[patent_title] => 'System for measuring the efficacy of a sterilization cycle'
[patent_app_type] => 1
[patent_app_number] => 9/078219
[patent_app_country] => US
[patent_app_date] => 1998-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 7397
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 179
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/063/06063591.pdf
[firstpage_image] =>[orig_patent_app_number] => 078219
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/078219 | System for measuring the efficacy of a sterilization cycle | May 12, 1998 | Issued |
Array
(
[id] => 4112905
[patent_doc_number] => 06046020
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-04-04
[patent_title] => 'Use of anti-capsule agents in microbiological testing'
[patent_app_type] => 1
[patent_app_number] => 9/075562
[patent_app_country] => US
[patent_app_date] => 1998-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8651
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/046/06046020.pdf
[firstpage_image] =>[orig_patent_app_number] => 075562
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/075562 | Use of anti-capsule agents in microbiological testing | May 4, 1998 | Issued |
Array
(
[id] => 6624705
[patent_doc_number] => 20020086277
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-07-04
[patent_title] => 'DETERMINATION OF ANTIBIOTIC EFFICACY IN TREATING MICROBIAL INFECTION'
[patent_app_type] => new
[patent_app_number] => 09/073155
[patent_app_country] => US
[patent_app_date] => 1998-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4009
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0086/20020086277.pdf
[firstpage_image] =>[orig_patent_app_number] => 09073155
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/073155 | DETERMINATION OF ANTIBIOTIC EFFICACY IN TREATING MICROBIAL INFECTION | May 4, 1998 | Abandoned |
Array
(
[id] => 3922873
[patent_doc_number] => 05945297
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-08-31
[patent_title] => 'Process for screening candidate agents that modulate the hemostatic system'
[patent_app_type] => 1
[patent_app_number] => 9/069888
[patent_app_country] => US
[patent_app_date] => 1998-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6040
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/945/05945297.pdf
[firstpage_image] =>[orig_patent_app_number] => 069888
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/069888 | Process for screening candidate agents that modulate the hemostatic system | Apr 28, 1998 | Issued |
Array
(
[id] => 6000865
[patent_doc_number] => 20020028923
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-03-07
[patent_title] => 'IDENTIFICATION OF GENETIC TARGETS FOR MODULATION BY OLIGONUCLEOTIDES AND GENERATION OF OLIGONUCLEOTIDES FOR GENE MODULATION'
[patent_app_type] => new
[patent_app_number] => 09/067638
[patent_app_country] => US
[patent_app_date] => 1998-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 30959
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 40
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0028/20020028923.pdf
[firstpage_image] =>[orig_patent_app_number] => 09067638
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/067638 | System of components for preparing oligonucleotides | Apr 27, 1998 | Issued |
Array
(
[id] => 4350311
[patent_doc_number] => 06190522
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-02-20
[patent_title] => 'Analysis of carbohydrates derivatized with visible dye by high-resolution polyacrylamide gel electrophoresis'
[patent_app_type] => 1
[patent_app_number] => 9/066184
[patent_app_country] => US
[patent_app_date] => 1998-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 9
[patent_no_of_words] => 4622
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/190/06190522.pdf
[firstpage_image] =>[orig_patent_app_number] => 066184
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/066184 | Analysis of carbohydrates derivatized with visible dye by high-resolution polyacrylamide gel electrophoresis | Apr 23, 1998 | Issued |
| 09/064994 | PREGNAN-3-OL-20-ONES | Apr 22, 1998 | Abandoned |
Array
(
[id] => 4174568
[patent_doc_number] => 06083932
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-07-04
[patent_title] => 'Pharmaceutical compositions derived from ginseng and methods of treatment using same'
[patent_app_type] => 1
[patent_app_number] => 9/061961
[patent_app_country] => US
[patent_app_date] => 1998-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 36
[patent_no_of_words] => 11060
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/083/06083932.pdf
[firstpage_image] =>[orig_patent_app_number] => 061961
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/061961 | Pharmaceutical compositions derived from ginseng and methods of treatment using same | Apr 16, 1998 | Issued |
Array
(
[id] => 3975867
[patent_doc_number] => 05958421
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-09-28
[patent_title] => 'Cosmetic or pharmaceutical composition containing an andiroba extract'
[patent_app_type] => 1
[patent_app_number] => 9/059339
[patent_app_country] => US
[patent_app_date] => 1998-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2094
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/958/05958421.pdf
[firstpage_image] =>[orig_patent_app_number] => 059339
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/059339 | Cosmetic or pharmaceutical composition containing an andiroba extract | Apr 13, 1998 | Issued |
| 09/045400 | NOVEL NUCLEIC ACID SEQUENCES OBTAINED FROM CDNA LIBRARIES OF HUMAN BONE MARROW AND HUMAN FETAL BRAIN | Mar 29, 1998 | Abandoned |
Array
(
[id] => 1005588
[patent_doc_number] => 06906185
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-06-14
[patent_title] => 'Derivatives of 7-deaza -2′-deoxyguanosine-5\'-triphosphate, preparation and use thereof'
[patent_app_type] => utility
[patent_app_number] => 09/045732
[patent_app_country] => US
[patent_app_date] => 1998-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6677
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/906/06906185.pdf
[firstpage_image] =>[orig_patent_app_number] => 09045732
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/045732 | Derivatives of 7-deaza -2′-deoxyguanosine-5'-triphosphate, preparation and use thereof | Mar 19, 1998 | Issued |
Array
(
[id] => 4138517
[patent_doc_number] => 06060311
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-05-09
[patent_title] => 'Retinoid suppression of ventricular muscle cell hypertrophy'
[patent_app_type] => 1
[patent_app_number] => 9/041050
[patent_app_country] => US
[patent_app_date] => 1998-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 7
[patent_no_of_words] => 14099
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/060/06060311.pdf
[firstpage_image] =>[orig_patent_app_number] => 041050
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/041050 | Retinoid suppression of ventricular muscle cell hypertrophy | Mar 9, 1998 | Issued |
Array
(
[id] => 4181297
[patent_doc_number] => 06037456
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-03-14
[patent_title] => 'Process for isolating and purifying viruses, soluble proteins and peptides from plant sources'
[patent_app_type] => 1
[patent_app_number] => 9/037751
[patent_app_country] => US
[patent_app_date] => 1998-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 1
[patent_no_of_words] => 16388
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/037/06037456.pdf
[firstpage_image] =>[orig_patent_app_number] => 037751
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/037751 | Process for isolating and purifying viruses, soluble proteins and peptides from plant sources | Mar 9, 1998 | Issued |